Cargando…
Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies
Objective To estimate the relative risks of death, myocardial infarction, stroke, and renal failure or dysfunction between antifibrinolytics and no treatment following the suspension of aprotinin from the market in 2008 for safety reasons and its recent reintroduction in Europe and Canada. Design Sy...
Autores principales: | Hutton, Brian, Joseph, Lawrence, Fergusson, Dean, Mazer, C David, Shapiro, Stan, Tinmouth, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438881/ https://www.ncbi.nlm.nih.gov/pubmed/22968722 http://dx.doi.org/10.1136/bmj.e5798 |
Ejemplares similares
-
Antifibrinolytics and Cardiac Surgery: The Past, The Present, and The Future
por: Aggarwal, Naresh K, et al.
Publicado: (2020) -
Antifibrinolytics in liver surgery
por: Makwana, Jalpa, et al.
Publicado: (2010) -
The Safety and Efficacy of Antifibrinolytic Therapy in Neonatal Cardiac Surgery
por: Lin, Chih-Yuan, et al.
Publicado: (2015) -
Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014) -
Efficacy and Safety of Using Antifibrinolytic Agents in Spine Surgery: a Meta-Analysis
por: Yuan, Chaoqun, et al.
Publicado: (2013)